Please enter the email address you used to register, then we will send you a link to choose a new password
ALZN: 248% | Alzamend Neuro Partners With Massachusetts General Hospital For First-of-Its-Kind Phase II Study Of AL001 For PTSD Treatment
ZIM: 18% | ZIM Integrated Shipping Services shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 guidance.
LQDA: -40% | Liquidia shares are trading lower. The company announced that the FDA granted tentative approval of YUTREPIA inhalation powder to treat adults with pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.
Posted In: ALZN LQDA ZIM